Form 4: Qualys Director Sells Shares Under 10b5-1 Plan

Qualys Director Wendy Pfeiffer sold 200 shares of common stock for $129.72 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Director Wendy Pfeiffer of Qualys, Inc. (QLYS) sold 200 shares of common stock.
• The transaction occurred on August 15, 2025, at a price of $129.72 per share.
• The sale was executed under a Rule 10b5-1 trading plan, which was adopted on February 21, 2025.
• Following this transaction, Wendy Pfeiffer directly owns 11,082 shares of Qualys common stock.

Sentiment

Score: 5

Explanation: Neutral. The filing is a standard disclosure of an insider stock sale. The sale was pre-planned under a 10b5-1 plan, which mitigates negative sentiment often associated with insider sales, making it a routine event.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reaction to new, non-public information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the insider's direct stake in the company.

Industry Context

This is a routine insider transaction disclosure for a director of a cybersecurity company. Such transactions are common and often pre-scheduled, not necessarily indicative of broader industry trends.

Related Party Transactions

• Director Wendy Pfeiffer's sale of 200 shares of Qualys common stock is a related party transaction as she is an insider.

Stakeholder Impact

• Shareholders: The sale reduces the director's direct ownership, which could be interpreted in various ways, though the 10b5-1 plan suggests it's not based on new information.

Key Dates

Recommendation

The filing is a routine Form 4 disclosure of an insider stock sale executed under a pre-arranged 10b5-1 plan. This type of transaction is generally not considered a strong indicator for investment decisions as it's often for personal financial planning rather than a reflection of the company's immediate prospects. The small number of shares sold (200) relative to the company's market capitalization also suggests minimal impact. Therefore, the filing itself does not provide new information warranting a change in investment stance; a 'hold' recommendation is appropriate as it does not alter the fundamental investment thesis for Qualys.

Keywords

Qualys, QLYS, Insider Trading, Form 4, Stock Sale, Director, 10b5-1 Plan, Equity Transaction